Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 3 years.
Humacyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 10, 202590.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 20, 2025 | Humacyte Inc. | Open-market sale | −591,685 | $1.58 | $934,862 |
| Aug 19, 2025 | Humacyte Inc. | Open-market sale | −1,100,000 | $1.63 | $1,793,000 |
| Aug 18, 2025 | Humacyte Inc. | Open-market sale | −549,360 | $1.83 | $1,005,329 |
| Nov 20, 2024 | Humacyte Inc. | Open-market sale | −261,369 | $4.40 | $1,150,024 |
| Nov 19, 2024 | Humacyte Inc. | Open-market purchase | +1,797 | $4.44 | $7,979 |
| Nov 19, 2024 | Humacyte Inc. | Open-market sale | −427,459 | $4.34 | $1,855,172 |
| Nov 18, 2024 | Humacyte Inc. | Open-market sale | −811,172 | $4.44 | $3,601,604 |
| Sep 10, 2024 | Humacyte Inc. | Open-market sale | −288,674 | $5.23 | $1,509,765 |
| Sep 9, 2024 | Humacyte Inc. | Open-market sale | −157,704 | $5.42 | $854,756 |
| Aug 29, 2024 | Humacyte Inc. | Open-market purchase | +1,222 | $6.55 | $8,004 |
| Aug 29, 2024 | Humacyte Inc. | Open-market sale | −352,112 | $6.35 | $2,235,911 |
| Aug 28, 2024 | Humacyte Inc. | Open-market sale | −277,090 | $6.47 | $1,792,772 |
| Aug 27, 2024 | Humacyte Inc. | Open-market sale | −252,676 | $6.71 | $1,695,456 |
| Jun 12, 2024 | Humacyte Inc. | Open-market sale | −271,518 | $7.30 | $1,982,081 |
| Jun 11, 2024 | Humacyte Inc. | Open-market sale | −282,000 | $7.09 | $1,999,380 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.